Lisdexamfetamin e Market
Lisdexamfetamine Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Lisdexamfetamine Market Size and Growth
The Lisdexamfetamine market is expanding due to rising ADHD diagnoses and increased prescription rates. The global market size was valued at approximately $5 billion in 2023, with projected growth driven by awareness and healthcare access. Innovative formulations and strategic partnerships are enhancing market dynamics amid regulatory challenges.
Companies Covered (Covid 19 Impact Covered)
The Lisdexamfetamine market is dominated by Takeda, which actively promotes its ADHD treatment through effective marketing and research. Competitors like Shire and Teva enhance market growth via strategic partnerships and expanding indications. Notable sales figures include Takeda at approximately $1.5 billion, Shire around $1.2 billion, and Teva near $800 million.
Request Sample Report
◍ Takeda
Market Segmentation
By Application
ADHD in Adults
ADHD in Children
B.E.D. in Adults
Request Sample Report
By Product
Capsule
Chewable Tablet
Market Growth
Request Sample Report
$ 3.02 Billion
